NHS London Procurement Partnership (hosted by Guy's and St Thomas' NHS Foundation Trust) is setting up a framework agreement for the provision of homecare medicine services which includes:

— low tech (Lot 1),

— mid tech (Lot 2), and

— high tech (Lot 3) homecare services.

This framework will involve the provisions of:

• dispense and delivery (ambient and fridge lines),

• compounding fees and delivery,

• nurse visits (training),

• nurse administration,

• waste removal,

• provision of refrigeration equipment,

• prescription management,

• standard ancillaries and equipment,

• access to CMU contract prices via homecare suppliers.

The framework agreement will operate for an initial term of 24 months with an option to extend for a further 12 months + 12 months.

Please refer to the ITT (Invitation to Tender) document for more information.

It is expected that suppliers should be able to deliver all the standards set out in the suite of documents submitted as part of this framework agreement.

Please note that Lot 3 has been split further in to sub-Lots (please refer to section II.2). for further information).

Lot 1: Low tech homecare services

Provision of low tech homecare Services is captured by Lot 1. This Lot includes, but is not limited to:

• HIV;

• Hepatitis;

• Immunosuppression;

• Oral and inhaled antibiotic products;

• Basic dispense and deliver services for licensed products including oral chemotherapy* (* RPS defines oral chemo as a mid tech service, however it is considered low tech for this framework unless the call-off contract includes the provision of phlebotomy services).

Provision of a mid tech homecare services is captured by Lot 2. This lot includes, but is not limited to:

• Erythropoetin Stimulating Agents (ESA);

• Self-injection Methotrexate;

• Self-injectable Biologic products for Rheumatology, Dermatology, Gastroenterology;

• Services requiring the provision of nurse training/support or unlicensed medicines.

Description of the procurement:

Provision of a high tech homecare services is captured by Lot 3. This Lot includes, but is not limited to:

• Aseptic products;

• OPAT;

• Products requiring equipment/ancils for administration.

Lot 3 is divided into 5 sub lots:

• Lot 3A: Immunoglobulins, C1 esterase inhibitors and other products for treating hereditary angiodema;

• Lot 3B: Biological products;

• Lot 3C: IntravenousIron Chelator;

• Lot 3D: Injectable medicines used for the treatment of cancers and other haematological conditions;

• Lot 3E: Outpatient Antimicrobial Therapy (OPAT).